Posted in | News

Archstone Purchases New Property in San Francisco

Archstone, a company engaged in investment and operations of apartments, declared that it has purchased a development site measuring 3.15 acres in the Potrero Hill area in San Francisco.

The company is planning to construct a 467-unit building a comfortable apartment community over the tract of land situated at the bend of 16th and 7th streets besides Southern Embarcadero Freeway. The company anticipates commencing construction by 2012 August.

Archstone Van Ness Washington DC. Credit: Archstone

The proposed construction site is located close to a number of high-technology companies in the Showplace Square and South of Market localities. Moreover, the Mission Bay neighborhood, which remains close to the location anticipates generating thousands of employment opportunities due to the upcoming new developments such as global headquarters of salesforce.com and the Medical Center of University of California at San Francisco.

The San Francisco apartments located close to the Bay Area Rapid Transit station and CalTrain transport facilities will provide easy transportation facilities for the residents who work outside the San Francisco area. The public transportation system also provides easy reach to a range of major employment providing companies located in the East Bay and Silicon Valey.

The other important facilities located within a mile range from the development site include entertainment locations such as Bottom of the Hill, the San Francisco Design Center and the Axis Café. Also a number of local restaurants and boutique shops remain close to the property.

Source: http://www.archstoneapartments.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Archstone Purchases New Property in San Francisco. AZoBuild. Retrieved on November 22, 2024 from https://www.azobuild.com/news.aspx?newsID=14398.

  • MLA

    Scanlon, Joel. "Archstone Purchases New Property in San Francisco". AZoBuild. 22 November 2024. <https://www.azobuild.com/news.aspx?newsID=14398>.

  • Chicago

    Scanlon, Joel. "Archstone Purchases New Property in San Francisco". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14398. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. Archstone Purchases New Property in San Francisco. AZoBuild, viewed 22 November 2024, https://www.azobuild.com/news.aspx?newsID=14398.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.